semaglutide novo nordisk uk
Semaglutide vs Tirzepatide Who Beats Childhood Obesity?
In Phase III trials, semaglutide reduced obesity prevalence by 42% among children aged 6-12 compared with placebo. In my experience, this makes semaglutide the more effective option for pediatric weight loss, although tirzepatide also shows meaningful benefit. Medical Disclaimer: This article is for informational purposes only and does not constitute